 |
|
Dopamine agonist can prevent ovarian hyperstimulation syndrome in IVF patients
June 22, 2006A class of drug widely used in a number of gynaecological conditions can prevent ovarian hyperstimulation syndrome (OHSS), an infrequent but serious complication of assisted reproduction treatments, a scientist told the 22nd annual conference of the European Society of Human Reproduction and Embryology in Prague, Czech Republic, on Wednesday 21 June 2006. Dr. Claudio Alvarez, from the Instituto Valenciano de Infertilidad, Valencia, Spain, said that his team's work, using the dopamine agonist cabergoline, was the first successful attempt to prevent this disorder.
OHSS can occur when drugs are used to stimulate the ovaries to produce the eggs needed for fertilization in IVF treatment. The ovaries become larger than normal, and there can be a build-up of fluid in the abdomen. In severe cases there may also be hemoconcentration (decrease of the fluid content of the blood, with a resulting increase in its concentration), and kidney and liver damage; this can be life-threatening. Although OHSS has been known for many years, until now it has been treated empirically and the underlying causes have been little understood.
Animal models had shown that increased vascular permeability (VP), a factor in OHSS, was associated with an increased expression in the ovary of vascular endothelial growth factor (VEGF), responsible for the growth of blood vessels. The binding of VEGF to its receptor VEGFR2 increases VP. "We knew that dopamine and its agonists also reverse increased VP in hyperstimulated animals", said Dr. Alvarez, "so we decided to see whether it could prevent OHSS in women undergoing ovarian stimulation for ART."
Dopamine agonists are widely used in gynaecological conditions, especially in patients with hyperprolactinemia—a condition where the presence of abnormally high levels of the hormone, prolactine, can cause a number of disorders affecting fertility — and their safety record is good. So Dr. Alvarez and his team began a study of 54 egg donors, who were randomly allocated into two groups immediately after administration of human chorionic gonadotropin (hCG), a drug used to induce ovulation.
The study group received 0.5 mg of the dopamine agonist cabergoline and the control group took placebo. The women were monitored every 48 hours from day 0 (the day hCG was given) to day 8. There were significant differences between the two groups.
"We found that cabergoline reduced hemoconcentration, ascites (excess fluid in the space between the membranes lining the abdomen and abdominal organs) and the incidence of moderate to severe OHSS in women at risk," said Dr. Alvarez. "Our next move will be to study the action of dopamine agonists in more detail, and to proceed to bigger studies of their effects in clinical trials. We hope that our work will enable us to better understand the mechanism of development of this serious complication of ART treatment, and to be able to treat it effectively."
European Society for Human Reproduction and Embryology
Dopamine agonists are widely used in gynaecological conditions, especially in patients with hyperprolactinemia—a condition where the presence of abnormally high levels of the hormone, prolactine, can cause a number of disorders affecting fertility — and their safety record is good. So Dr. Alvarez and his team began a study of 54 egg donors, who were randomly allocated into two groups immediately after administration of human chorionic gonadotropin (hCG), a drug used to induce ovulation.
The study group received 0.5 mg of the dopamine agonist cabergoline and the control group took placebo. The women were monitored every 48 hours from day 0 (the day hCG was given) to day 8. There were significant differences between the two groups.
"We found that cabergoline reduced hemoconcentration, ascites (excess fluid in the space between the membranes lining the abdomen and abdominal organs) and the incidence of moderate to severe OHSS in women at risk," said Dr. Alvarez. "Our next move will be to study the action of dopamine agonists in more detail, and to proceed to bigger studies of their effects in clinical trials. We hope that our work will enable us to better understand the mechanism of development of this serious complication of ART treatment, and to be able to treat it effectively."
European Society for Human Reproduction and Embryology
Dopamine Current Events and Dopamine News RSSSinging to females makes male birds' brains happy
The melodious singing of birds has been long appreciated by humans, and has often been thought to reflect a particularly positive emotional state of the singer.
Study reveals specific gene in adolescent men with delinquent peers
Birds of a feather flock together, according to the old adage, and adolescent males who possess a certain type of variation in a specific gene are more likely to flock to delinquent peers.
Do 'light' cigarettes deliver less nicotine to the brain than regular cigarettes?
For decades now, cigarette makers have marketed so-called light cigarettes - which contain less nicotine than regular smokes - with the implication that they are less harmful to smokers' health. A new UCLA study shows, however, that they deliver nearly as much nicotine to the brain.
UNC study: Parenting can override effect of genes in how babies respond to stress
Everyone gets stressed, even babies. Now, it appears how infants respond to stress is linked to if they have a particular form of a certain gene, according to a new study from the University of North Carolina at Chapel Hill.
Early parenting plays key role in infants' physiological response to stress
In infancy, genes are the key influence on a child's ability to deal with stress. But as early as 6 months of age, parenting plays an important role in changing the impact of genes that may put infants at risk for responding poorly to stress.
First generation antipsychotic drugs as effective as newer ones in some children
Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or "atypical" drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications.
Protein found that regulates gene critical to dopamine-releasing brain cells
Researchers have identified a protein they say appears to be a primary player in maintaining normal functioning of an important class of neurons - those brain cells that produce, excrete and then reabsorb dopamine neurotransmitters.
Abuse of painkillers can predispose adolescents to lifelong addiction
No child aspires to a lifetime of addiction. But their brains might. In new research to appear online in the journal Neuropsychopharmacology this week, Rockefeller University researchers reveal that adolescent brains exposed to the painkiller Oxycontin can sustain lifelong and permanent changes in their reward system - changes that increase the drug's euphoric properties and make such adolescents more vulnerable to the drug's effects later in adulthood.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'.
New evidence on addiction to medicines Diazepam has effect on nerve cells in the brain reward system
Addictions to medicines and drugs are thought to develop over a relatively long period of time. The process involves both structural and functional changes in brain nerve cells that are still poorly understood.
More Dopamine Current Events and Dopamine News Articles
 | Dumb Bells & Dopamine: A Parkinson's Success Story by Arthur, W. Curren This book is about living with Parkinson's, an incurable, debilitating disease caused by the loss of dopamine-producing cells in the brain of the afflicted person. Levodopa is the only drug that replaces some of the dopamine and exercise is the only activity that induces the brain to produce dopamine. The author uses a rigorous exercise program to reduce the dosage of levodopa and extend the... |
 | Dopamine, Volume 21 (Handbook of Chemical Neuroanatomy) Dopamine is a major neurotransmitter of the brain involved in the control of movement, emotion, and cognition; disturbance in dopamine function is associated with disorders like Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. This volume of the Handbook of Chemical Neuroanatomy provides a series of in depth critical reviews of our present understanding of the most... |
 | Dopamine Research Advances |
 | Dopamine Transporters: Chemistry, Biology, and Pharmacology (Wiley Series in Drug Discovery and Development) Understanding the dopamine transporter can lead to new therapies for neurological disorders This book consolidates current information on the dopamine transporter (DAT) in relationto medicinal chemistry and synthesis, biology and pathology, and pharmacology. Because of DAT's role in diseases such as Parkinson's, schizophrenia, attention deficit hyperactivity disorder (ADHD), Tourette... |
 | Dopamine in the Pathophysiology and Treatment of Schizophrenia: New Findings Covering the latest advances in the field, Dopamine in the Treatment of Schizophrenia, Second Edition provides a detailed explanation of the etiology and clinical presentation of the disease, especially as related to the dopamine system. Written by an international team of experts, the text identifies genetic polymorphisms that affect dopaminergic neurotransmission and their possible impact on... |
 | Dopamine in the CNS I (Handbook of Experimental Pharmacology) Dopamine was initially regarded as a mere precursor of noradrenaline, but has progressively gained its present status of a common target for major drug classes and a substrate for some basic functions and dysfunctions of the Central Nervous System. The scientific interest has shifted from typically motor areas of the striatum to traditionally limbic ones as the nucleus accumbens and its afferent... |
 | Progress in Dopamine Research Schizophrenia: A Guide for Physicians This handy pocket book provides a summary of research on the role of dopamine in the cause and clinical presentation of schizophrenia. It includes an overview of the history and etiology of schizophrenia, as well as a review of schizophrenia and modern management. It highlights the genetics of schizophrenia, including the function of dopamine and 5HT receptors, COMT, and drug metabolism. It... |
| The Role of Brain Dopamine (Basic and Clinical Aspects of Neuroscience, Vol 3) | |
| Distribution of the 3' VNTR Polymorphism in the Human Dopamine Transporter Gene in World Populations.: An article from: Human Biology by R.j. Mitchell, S. Howlett, L. Earl, N.g. White, J. Mccomb, M.s. Schanfield, I. Briceno, S.s. Papiha, L. Osipova, G. Livshits, W.r. Leonard, M.h. Crawford This digital document is an article from Human Biology, published by Wayne State University Press on April 1, 2000. The length of the article is 4403 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Parkinson's Disease: The Life Cycle of the Dopamine Neuron (Annals of the New York Academy of Sciences) Parkinson's Disease (PD), a progressive neurological disorder arising from degeneration of dopaminergic neurons in the substantia nigra region of the brain, is characterized by impairment of movement control. It progresses from symptoms such as tremor and muscular rigidity to total disability and death. This volume focuses on the dopaminergic system from a developmental perspective, with the... |
| © 2008 BrightSurf.com |